메인메뉴 바로가기 본문내용 바로가기

News & Notice

home > Center for Narcotics Information Management > News & Notice

Contents
TITLE [Press Release] Narcotics Multi-Prescription Review (NMPR)
WRITER NIMS DATE 2020-09-22 HIT 693

Narcotics Multi-Prescription Review (NMPR)


What is Narcotics Multi-Prescription Review?

The amended Narcotics Control Act 2019 allows doctors to request and receive patient prescription history collected by Narcotics Information Management System (NIMS) during a consultation. Prescribers can decide not to prescribe narcotic or psychotropic drugs if patient history concerns drug overuse and abuse.

In compliance with the law, Korea Institute of Drug Safety and Risk Management (designated as the Center for Narcotics Information Management) provides an information service called the 'Narcotics Multi-Prescription Review (NMPR)' at data.nims.or.kr.


Why is Narcotics Multi-Prescription Review necessary?

To prevent patients from going to multiple medical institutions for extra drugs, it is necessary to build an effective doctor-shopping monitoring tool for prescribers.

It is often difficult to determine adequate treatment without knowing patient history, especially when the doctor is concerned with patients' drug overuse or misuse.
NMPR allows doctors to check patients’ previous prescription history collected by NIMS to minimize overuse or abuse of medicinal narcotic drugs.


Who has access to a patient record in Narcotics Multi-Prescription Review?

Medical practitioners handling narcotics specified by the Narcotics Control Act have access to NMPR. By license type, clinical doctors and dentist are applicable in this case. Veterinarians and Korean traditional medicine doctors (oriental medical doctors) do not have access to NMPR because they do not prescribe narcotic or psychotropic drugs.


What kinds of patient records are provided in Narcotics Multi-Prescription Review?

NMPR provides information including drug administration and prescription date, type and address of medical institution, brand name, drug classification, active ingredient, dose, and prescribed dosage details.

Based on the date of inquiry, prescribers can search patient history up to one year.


How is patient privacy protected under law?

Doctors who wish to view patient history to minimize drug overuse and double-doctoring must notify the patient in advance. 

Personal information may not be used or provided to a third party for any purpose other than that for which it was collected. Anyone in breach of the law shall be punished by imprisonment with labor for not more than five years or by a fine not exceeding 50 million won.


How does Narcotics Multi-Prescription Review collect prescription information?

Prescription information is automatically collected from NIMS, which medical institutions and pharmacies must report to every time they administer or prescribe narcotic and psychotropic drugs.


What medicines are monitored through Narcotics Multi-Prescription Review?

As for 2020, NMPR provides patient history information for three types of drugs, propofol, zolpidem, and appetite suppressant, which are often misused among narcotic drugs. By 2021, the scope of the provision will be expanded to all narcotic and psychotropic drugs.

FILES

한국의약품안전관리원